| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $138.9M | +1.1% |
| Cost of Revenue | $73.9M | +36.1% |
| Gross Profit | $65.0M | -21.8% |
| R&D Expense | $35.9M | +15.6% |
| SG&A Expense | $138.0M | +35.8% |
| Operating Income | -$125.5M | -138.6% |
| Pre-tax Income | -$112.3M | -194.7% |
| Income Tax | -$5.1M | -1280.0% |
| Net Income | -$107.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.8M | -47.4% |
| Accounts Receivable | $30.0M | -6.7% |
| Inventory | $54.8M | +67.1% |
| Current Assets | $212.3M | -41.6% |
| Total Assets | $418.8M | +3.0% |
| Current Liabilities | $74.8M | +78.0% |
| Total Liabilities | $123.0M | +60.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.2M | -119.6% |
| Capital Expenditures | $2.6M | -22.4% |
| Investing Cash Flow | $50.2M | +161.1% |
| Financing Cash Flow | -$708K | -255.3% |
| Free Cash Flow | -$79.8M | -107.2% |
| -178.1% |
| EPS (Basic) | -$2.51 | -151.0% |
| EPS (Diluted) | -$2.51 | -151.0% |
| Stockholders' Equity |
| $295.7M |
| -10.4% |